TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12357876

Group type: EXPERIMENTAL
Intervention: True feed (cow's milk)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo meals
Number of subjects: 154
Study: 10430680

Group type: EXPERIMENTAL
Intervention: Bipolar cutting forceps (BPCF)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Harmonic coagulating shears (HCS)
Number of subjects: 86
Study: 7593517

Group type: EXPERIMENTAL
Intervention: Nafarelin (200 micrograms twice daily as a nasal spray)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Nafarelin
Number of subjects: 188
Study: 1351705

Group type: EXPERIMENTAL
Intervention: Atropine 10 micrograms/kg with neostigmine 40 micrograms/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Atropine 15 micrograms/kg with neostigmine 40 micrograms/kg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Atropine 20 micrograms/kg with neostigmine 40 micrograms/kg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as no atropine)
Number of subjects: 36
Study: 3833371

Group type: EXPERIMENTAL
Intervention: Liquid capsules (1 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oral tablets (1 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Liquid capsules
Number of subjects: 18
Study: 29521723

Group type: EXPERIMENTAL
Intervention: Large Balloon Dilation (LBD)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Mechanical Lithotripsy (ML)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 98
Study: 29476847

Group type: EXPERIMENTAL
Intervention: Double high-level disinfection (HLD)
Number of subjects: 2925

Group type: COMPARATOR
Intervention: Single high-level disinfection (HLD)
Number of subjects: 2925
Study: 26885787

Group type: EXPERIMENTAL
Intervention: Dapsone 5% gel (twice daily) with oral doxycycline hyclate 100mg (once daily) for 12 weeks, followed by dapsone 5% gel (twice daily) for 12 weeks
Number of subjects: 30
Study: 25282345

Group type: EXPERIMENTAL
Intervention: Mother‐Infant Transaction Program (MITP)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Preterm control group (standard hospital care)
Number of subjects: 146
Study: 22938706

Group type: EXPERIMENTAL
Intervention: Tiotropium (5 μg once daily for 48 weeks)
Number of subjects: 912

Group type: COMPARATOR
Intervention: Placebo (once daily for 48 weeks)
Number of subjects: 912
Study: 20920800

Group type: EXPERIMENTAL
Intervention: Yoga (12 weekly 75-min sessions plus written advice)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual care (plus written advice)
Number of subjects: 20
Study: 17608255

Group type: EXPERIMENTAL
Intervention: Boussignac CPAP
Number of subjects: 19

Group type: COMPARATOR
Intervention: Nasal catheter (control)
Number of subjects: 19
Study: 16060739

Group type: EXPERIMENTAL
Intervention: Vertical position in space (intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motor responses implying vertical movement (intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vertical position (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: N/A (control)
Number of subjects: 0
Study: 12012079

Group type: EXPERIMENTAL
Intervention: Bicarbonate supplement (0.3 g x kg(‐1) of body mass)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo mixture
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bicarbonate supplement
Number of subjects: 10
Study: 10078718

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine 1,200 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7549384

Group type: EXPERIMENTAL
Intervention: Zhengda Zhenhua 851‐R oral liquor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 2154855

Group type: EXPERIMENTAL
Intervention: Cisplatin plus etoposide (cisplatin 120 mg/m2, etoposide 100 mg/m2, days 1 to 3)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Carboplatin plus etoposide (carboplatin 325 mg/m2, etoposide 100 mg/m2, days 1 to 3)
Number of subjects: 162
Study: 389813

Group type: EXPERIMENTAL
Intervention: 410 mg sulphadiazine + 90 mg trimethoprim (SD + TMP)
Number of subjects: 78

Group type: COMPARATOR
Intervention: 800 mg sulphamethoxazole + 160 mg trimethoprim (SMZ + TMP)
Number of subjects: 78
Study: 31005968

Group type: EXPERIMENTAL
Intervention: Plasma cystathionine levels in patients with SAP
Number of subjects: 6703

Group type: EXPERIMENTAL
Intervention: Plasma cystathionine levels in patients with AMI
Number of subjects: 6703
Study: 28855224

Group type: EXPERIMENTAL
Intervention: n‐3 fatty acid preparation (1.7 g DHA and 0.6 g EPA daily for 6 months)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 26461872

Group type: EXPERIMENTAL
Intervention: Blue collar workers
Number of subjects: 1700

Group type: EXPERIMENTAL
Intervention: Service workers
Number of subjects: 1700

Group type: EXPERIMENTAL
Intervention: Service and blue collar workers
Number of subjects: 1700

Group type: EXPERIMENTAL
Intervention: White collar workers
Number of subjects: 1700
Study: 23416815

Group type: EXPERIMENTAL
Intervention: Functional Endoscopic Sinus Surgery (FESS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional surgical procedure
Number of subjects: 60
Study: 21813074

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Olanzapine/+valproic acid
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Risperidone/+valproic acid
Number of subjects: 160
Study: 20001608

Group type: EXPERIMENTAL
Intervention: HIV-positive patients with HAD
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Patients with HAD
Number of subjects: 33

Group type: COMPARATOR
Intervention: Non-HIV controls
Number of subjects: 33
Study: 17419010

Group type: EXPERIMENTAL
Intervention: Metabolic stressor
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 15448205

Group type: EXPERIMENTAL
Intervention: PKC412 (N‐benzoyl‐staurosporine)
Number of subjects: 1
Study: 11306214

Group type: EXPERIMENTAL
Intervention: Methadone treatment interventions
Number of subjects: 150
Study: 9337190

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 557

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 557
Study: 7957502

Group type: EXPERIMENTAL
Intervention: Oral treatment with DDAVP
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Endonasal treatment with DDAVP
Number of subjects: 7

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 7
Study: 3661642

Group type: EXPERIMENTAL
Intervention: 10 mg of nadolol twice daily
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 20 mg of nadolol twice daily
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31490858

Group type: EXPERIMENTAL
Intervention: Chemotherapy-periodized exercise prescription
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard linear exercise prescription
Number of subjects: 27
Study: 30070193

Group type: EXPERIMENTAL
Intervention: Availability of healthy foods sold from school canteens (intervention from a larger RCT)
Number of subjects: 50
Study: 28431543

Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty (type Müller Straight Stem)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Uncemented hemiarthroplasty (type DB‐10)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty
Number of subjects: 201

Group type: COMPARATOR
Intervention: Uncemented hemiarthroplasty
Number of subjects: 201
Study: 25322952

Group type: EXPERIMENTAL
Intervention: Endoscopic nasobiliary drainage (ENBD) after endoscopic papillary balloon dilation (EPBD)
Number of subjects: 93

Group type: COMPARATOR
Intervention: No endoscopic nasobiliary drainage (No-ENBD) after endoscopic papillary balloon dilation (EPBD)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both groups (ENBD and No-ENBD)
Number of subjects: 93
Study: 23739025

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BUP)
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BUP) and Methadone
Number of subjects: 1269
Study: 20547668

Group type: EXPERIMENTAL
Intervention: Neuromuscular training programme (dynamic stretching, eccentric strength, agility, jumping, balance, home-based balance training with a wobble board)
Number of subjects: 744

Group type: COMPARATOR
Intervention: Standardised warm-up (static and dynamic stretching, aerobic components) and home-based stretching programme
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Neuromuscular training programme
Number of subjects: 744
Study: 18406165

Group type: EXPERIMENTAL
Intervention: Liquid formulation of IV RhIG (300 microg IM in Study 1; 15 microg/kg IM in Study 2; 50 microg/kg IV in Study 1)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Lyophilized formulation of IV RhIG (300 microg IM in Study 1; 15 microg/kg IM in Study 2; 50 microg/kg IV in Study 1)
Number of subjects: 142
Study: 15944423

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 12388267

Group type: EXPERIMENTAL
Intervention: Dopamine hydrochloride (5, 10, and 15 microg x kg(‐1) x min(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11116420

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted (LA) colon resection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open (O) colon resection
Number of subjects: 0
Study: 8638788

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 50 micrograms
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 100 micrograms
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 200 micrograms
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine 50 micrograms
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine 100 micrograms
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine 200 micrograms
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Combination of 50 micrograms morphine + 50 micrograms neostigmine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 48
Study: 1538160

Group type: EXPERIMENTAL
Intervention: 750 mg ciprofloxacin with loperamide
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: 3-day course of 500 mg ciprofloxacin twice daily with loperamide
Number of subjects: 142

Group type: COMPARATOR
Intervention: 750 mg ciprofloxacin with placebo
Number of subjects: 142
Study: 6709544

Group type: EXPERIMENTAL
Intervention: High Carbohydrate (HC) meals (65% carbohydrate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High Fat (HF) meals (12% carbohydrate, 71% fat)
Number of subjects: 10
Study: 30079814

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 28990434

Group type: EXPERIMENTAL
Intervention: NMES combined with strengthening exercise
Number of subjects: 100

Group type: COMPARATOR
Intervention: Only NMES
Number of subjects: 100
Study: 26433546

Group type: EXPERIMENTAL
Intervention: Xilonix plus standard of care
Number of subjects: 43
Study: 23295313

Group type: EXPERIMENTAL
Intervention: 12‐mo moderate‐intensity physical activity (PA)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Successful aging (SA) health education intervention
Number of subjects: 424
Study: 23018219

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) 5 or 10 mg daily for 13 weeks
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Placebo or gonadotropin-releasing hormone agonist
Number of subjects: 546
Study: 19101921

Group type: EXPERIMENTAL
Intervention: Befriending service with a Befriender Facilitator (BF) and trained lay volunteer befriender
Number of subjects: 236

Group type: COMPARATOR
Intervention: No BF contact (Control)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Befriending service
Number of subjects: 236
Study: 17205530

Group type: EXPERIMENTAL
Intervention: Non-aspirin NSAIDs (prescription for at least 1 year)
Number of subjects: 10336

Group type: EXPERIMENTAL
Intervention: Aspirin (prescription for at least 1 year)
Number of subjects: 10336

Group type: COMPARATOR
Intervention: No prescription of non-aspirin NSAIDs
Number of subjects: 10336
Study: 16115963

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 130/0.4 (HES)
Number of subjects: 132

Group type: COMPARATOR
Intervention: 3% modified fluid gelatin (GEL)
Number of subjects: 132
Study: 11840236

Group type: EXPERIMENTAL
Intervention: BiliCheck system (multiple wavelength analysis of reflectance data)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Jaundice Meter JM‐102 (two‐wavelength bilirubinometer)
Number of subjects: 101
Study: 10068848

Group type: EXPERIMENTAL
Intervention: Aprindine (60 mg daily)
Number of subjects: 38
Study: 7627485

Group type: EXPERIMENTAL
Intervention: Lunar dual-energy X-ray absorptiometry scanner
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hologic dual-energy X-ray absorptiometry scanner
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Norland dual-energy X-ray absorptiometry scanner
Number of subjects: 12

Group type: COMPARATOR
Intervention: Measurements from phantoms
Number of subjects: 12

Group type: COMPARATOR
Intervention: European Spine Phantom
Number of subjects: 12
Study: 1903497

Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg b.i.d. (increased to 40 mg per day after 8 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cholestyramine 8 g b.i.d. (added after 16 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Gemfibrocil 900 mg (two thirds of cholestyramine group switched)
Number of subjects: 45
Study: 7342466

Group type: EXPERIMENTAL
Intervention: Allyloestrenol (Gestanon) 10 mg daily until the 8th week, then 15 to 20 mg daily until the 12th week, then tapered off
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Allyloestrenol (Gestanon) administered immediately after ovulation
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Allyloestrenol (Gestanon) administered after the first missed period
Number of subjects: 198
Study: 29869444

Group type: EXPERIMENTAL
Intervention: AFXL-assisted MAL-PDT with 1-h incubation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional MAL-PDT (CPDT)
Number of subjects: 42
Study: 30149503

Group type: EXPERIMENTAL
Intervention: Genipap juice
Number of subjects: 16
Study: 25881805

Group type: EXPERIMENTAL
Intervention: Behavioral lifestyle intervention program
Number of subjects: 8
Study: 24501379

Group type: EXPERIMENTAL
Intervention: Tailored telephone counseling intervention
Number of subjects: 632

Group type: COMPARATOR
Intervention: Mailed packet with general information about screening
Number of subjects: 632
Study: 22714067

Group type: EXPERIMENTAL
Intervention: Follicular aspiration + flushing
Number of subjects: 200

Group type: COMPARATOR
Intervention: Follicular aspiration only
Number of subjects: 200
Study: 19576120

Group type: EXPERIMENTAL
Intervention: Nateglinide (120 mg, 3/d)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Acarbose (100 mg, 3/d)
Number of subjects: 237
Study: 17895886

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with 5‐fluorouracil (5‐FU) and leucovorin (LV)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Surveillance only
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with 5‐FU and LV
Number of subjects: 500
Study: 15648443

Group type: EXPERIMENTAL
Intervention: Collagen-like peptide gel (3% collagen-like peptide and 1% booster molecule)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 20
Study: 11164130

Group type: EXPERIMENTAL
Intervention: Vitamin E intake from supplements
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Dietary factors (including serum retinol, carotenoids, supplemental vitamin C, alpha-tocopherol intake from food, dietary fiber, and Hispanic ethnicity)
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Gamma-tocopherol intake from food, total fat intake, and BMI
Number of subjects: 1047

Group type: EXPERIMENTAL
Intervention: Age, income, hormone use, and geographic location
Number of subjects: 1047
Study: 9581724

Group type: EXPERIMENTAL
Intervention: Verapamil (240 mg twice daily) for 6 months
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 98
Study: 8043664

Group type: EXPERIMENTAL
Intervention: Subcutaneous (SC) insulin administration
Number of subjects: 6

Group type: COMPARATOR
Intervention: Intraperitoneal (IP) insulin administration
Number of subjects: 6
Study: 2927479

Group type: EXPERIMENTAL
Intervention: Conservative treatment (resuscitation with intravenous fluids, nasogastric suction, intravenous antibiotics including cefuroxime, ampicillin, metronidazole, and ranitidine)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Immediate laparotomy and repair of the perforation
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 83
Study: 48727

Group type: EXPERIMENTAL
Intervention: 10 percent glycerol for 6 days
Number of subjects: 61

Group type: COMPARATOR
Intervention: Dexamethasone (16 mg. per 24 hours for 6 days)
Number of subjects: 61
Study: 30102685

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MCT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 16
Study: 31094443

Group type: EXPERIMENTAL
Intervention: 8 month aerobic exercise program
Number of subjects: 175

Group type: COMPARATOR
Intervention: Sedentary after-school program
Number of subjects: 175
Study: 28878472

Group type: EXPERIMENTAL
Intervention: Centrifugal contraction exercise of the rectus abdominis during isometric contraction of the transversus abdominis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 25208848

Group type: EXPERIMENTAL
Intervention: Pretest screening before CIT
Number of subjects: 152
Study: 23759410

Group type: EXPERIMENTAL
Intervention: Website only (W)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Website, monthly group sessions, and follow-up calls (WG)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Website and SMS (WSMS)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 101
Study: 21486975

Group type: COMPARATOR
Intervention: Standard dosing schedule (0, 2, and 6 months)
Number of subjects: 903

Group type: EXPERIMENTAL
Intervention: Alternative dosing schedule (0, 3, and 9 months)
Number of subjects: 903

Group type: EXPERIMENTAL
Intervention: Alternative dosing schedule (0, 6, and 12 months)
Number of subjects: 903

Group type: EXPERIMENTAL
Intervention: Alternative dosing schedule (0, 12, and 24 months)
Number of subjects: 903
Study: 18277020

Group type: EXPERIMENTAL
Intervention: formoterol 4.5 microg bid
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: formoterol 9 microg bid
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: formoterol 18 microg bid
Number of subjects: 36

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: formoterol (all dosages)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: formoterol (higher dosages)
Number of subjects: 36
Study: 16485186

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RF ablation)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: RF ablation combined with left atrial size reduction
Number of subjects: 46
Study: 12588635

Group type: EXPERIMENTAL
Intervention: Propolis extract
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 10955199

Group type: EXPERIMENTAL
Intervention: Tretinoin gel microsphere, 0.1%
Number of subjects: 35

Group type: COMPARATOR
Intervention: Tretinoin cream, 0.025%
Number of subjects: 35
Study: 9709370

Group type: EXPERIMENTAL
Intervention: Short tubing/port (STP) setup with gravity flow
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Short tubing/port (STP) setup with manual pressure
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Short tubing/port (STP) setup with pneumatic pressure at 300 mm Hg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional (CON) setup with gravity flow
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional (CON) setup with manual pressure
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional (CON) setup with pneumatic pressure at 300 mm Hg
Number of subjects: 10
Study: 8150763

Group type: EXPERIMENTAL
Intervention: Cefepime 2 g every 12 h
Number of subjects: 231

Group type: COMPARATOR
Intervention: Cefotaxime 2 g every 8 h
Number of subjects: 231
Study: 3620277

Group type: EXPERIMENTAL
Intervention: Isoxicam 200 mg once daily
Number of subjects: 479

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily
Number of subjects: 479
Study: 29718782

Group type: EXPERIMENTAL
Intervention: COMPASS program (peer‐led group intervention)
Number of subjects: 28
Study: 28685553

Group type: EXPERIMENTAL
Intervention: Oxaliplatin and epirubicin
Number of subjects: 218

Group type: COMPARATOR
Intervention: Oxaliplatin
Number of subjects: 218
Study: 26216331

Group type: EXPERIMENTAL
Intervention: DTaP5‐IPV‐Hib‐HepB, PCV13, and RV5
Number of subjects: 1465

Group type: EXPERIMENTAL
Intervention: DTaP5‐IPV‐Hib‐HepB
Number of subjects: 1465

Group type: EXPERIMENTAL
Intervention: Solicited adverse events in group 1
Number of subjects: 1465

Group type: EXPERIMENTAL
Intervention: Fever in group 1
Number of subjects: 1465
Study: 23022285

Group type: EXPERIMENTAL
Intervention: Thiazolidinediones (TZDs) - pioglitazone and rosiglitazone
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 6-month pioglitazone treatment
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 20338054

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18922508

Group type: EXPERIMENTAL
Intervention: LEAP intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 16292592

Group type: EXPERIMENTAL
Intervention: Amitriptyline 25 mg nocturnally administered for 15 days
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 15061398

Group type: EXPERIMENTAL
Intervention: Montelukast + Cetirizine (M-C group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Montelukast + Desloratadine (M-D group)
Number of subjects: 30